Lee's Pharmaceutical Holdings Ltd (0950.HK)
9.95HKD
17 Jul 2018
HK$-0.05 (-0.50%)
HK$10.00
HK$10.00
HK$10.00
HK$9.82
453,000
1,733,688
HK$14.70
HK$6.01
Latest Key Developments (Source: Significant Developments)
Lee's Pharmaceutical Says Gets Approval For Conducting Clinical Trials For TG02 From China FDA
June 14 (Reuters) - Lee's Pharmaceutical Holdings Ltd <0950.HK>::CHINA FOOD AND DRUG ADMINISTRATION GRANTED APPROVAL FOR CONDUCTING CLINICAL TRIALS FOR TG02. Full Article
Lee's Pharmaceutical Posts Q1 Profit Attributable Of HK$70.2 Mln
May 24 (Reuters) - Lee's Pharmaceutical Holdings Ltd <0950.HK>::Q1 PROFIT ATTRIBUTABLE HK$70.2 MILLION VERSUS HK$46.4 MILLION.QTRLY REVENUE HK$281.905 MILLION VERSUS HK$226.200 MILLION. Full Article
Lee's Pharmaceutical Holdings says qtrly profit attributable HK$61.8 mln
Nov 23 (Reuters) - Lee's Pharmaceutical Holdings Ltd <0950.HK>:Qtrly profit attributable to owners of company HK$61.8 million versus HK$72.8 million.Qtrly revenue HK$275.0 million versus HK$248.9 million a year ago. Full Article
BRIEF-Lee's Pharmaceutical Holdings Says China FDA Grants Unit Approval For Clinical Trials
* CHINA FDA GRANTS UNIT APPROVAL FOR CLINICAL TRIALS FOR ITS RECOMBINANT HUMAN ANTI-PD-L1 MONOCLONAL ANTIBODY INJECTION Source text for Eikon: Further company coverage:
Earnings vs. 
Estimates